ArticlePerioperative medicine (London, England)2025
Effects of remote ischaemic preconditioning against acute kidney injury in cardiac surgery patients: a randomized controlled trial.
Article in Perioperative medicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04433468 (Study on the Protective Effect of RIPC in Patients Undergoing Cardiac Surgery.), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Study on the Protective Effect of RIPC in Patients Undergoing Cardiac Surgery.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAcute kidney injury (AKI) is a well-known, serious complication of cardiac surgery that is associated with increased morbidity and mortality. However, the effects of remote ischaemic preconditioning (RIPC) on AKI after cardiac surgery have shown inconsistent results. This study was conducted to evaluate the effects of RIPC on AKI in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB).
methodsIn this single-centre, prospective, randomized, double-blind, controlled trial, 240 patients undergoing elective cardiac surgery were assessed for eligibility. 180 patients were randomly assigned to either RIPC group or control (Con) group. Finally, 159 patients (79 to Con group and 80 to RIPC group) completed follow-up. RIPC was performed on an upper limb with repeated 5-min inflation and 5-min deflation for three times. The primary outcome was the proportion of AKI 48 h after surgery. Secondary outcomes included major clinical short-term outcomes and the incidences of postoperative complications, clinical diagnostic indicators serum creatinine (SCr), urinary novel biomarkers IGFBP7 and TIMP-2.
resultsThe proportion of AKI in RIPC group was significantly lower than Con group (Con versus RIPC: 26.6% vs. 13.8%; P = 0.044). In addition, RIPC resulted in a smaller increase in SCr levels 24 h (Con versus RIPC: 96.6 ± 35.9 µmol/L vs. 86.2 ± 24.9 µmol/L; P = 0.035) and 48 h (Con versus RIPC: 93.6 ± 45.2 µmol/L vs. 75.8 ± 30.8 µmol/L; P = 0.004) postoperatively. The postoperative concentrations of urinary biomarkers such as IGFBP7 and IGFBP7×TIMP-2 were lower in the RIPC group than in the Con group (P = 0.045 and 0.009, respectively). There were no significant differences in short-term outcomes and postoperative complications.
conclusionsIn this trial, RIPC reduced the proportion of AKI and the amplitude of SCr elevation 48 h postoperatively. RIPC may exert a certain renal protective effect by enhancing renal recovery in the early postoperative stage.
trial registrationClinicalTrials.gov identifier: NCT04433468.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.